CN113481189A - A sucrose isomerase mutant and its application - Google Patents

A sucrose isomerase mutant and its application Download PDF

Info

Publication number
CN113481189A
CN113481189A CN202110868362.2A CN202110868362A CN113481189A CN 113481189 A CN113481189 A CN 113481189A CN 202110868362 A CN202110868362 A CN 202110868362A CN 113481189 A CN113481189 A CN 113481189A
Authority
CN
China
Prior art keywords
leu
asp
asn
ala
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110868362.2A
Other languages
Chinese (zh)
Other versions
CN113481189B (en
Inventor
刘洋
郭川志
周晶辉
赵强
赵士敏
许岗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Flag Biotechnology Co ltd
Original Assignee
Hunan Flag Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Flag Biotechnology Co ltd filed Critical Hunan Flag Biotechnology Co ltd
Priority to CN202110868362.2A priority Critical patent/CN113481189B/en
Publication of CN113481189A publication Critical patent/CN113481189A/en
Application granted granted Critical
Publication of CN113481189B publication Critical patent/CN113481189B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/24Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y504/00Intramolecular transferases (5.4)
    • C12Y504/99Intramolecular transferases (5.4) transferring other groups (5.4.99)
    • C12Y504/99011Isomaltulose synthase (5.4.99.11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明属于酶工程技术领域,涉及一种蔗糖异构酶突变体及其应用。所述的突变体在SEQ ID NO.1所示氨基酸序列的野生型蔗糖异构酶中突变R434P与E273N。突变体较野生型蔗糖异构酶热稳定性和发酵活力均显著提高。利用突变体制备的固定化酶活力更高,稳定性显著增加,蔗糖转化率和异麦芽酮糖生成率有所提高,杂质含量更低,更适用于工业应用。The invention belongs to the technical field of enzyme engineering, and relates to a sucrose isomerase mutant and its application. Said mutants mutate R434P and E273N in the wild-type sucrose isomerase with the amino acid sequence shown in SEQ ID NO.1. Compared with the wild-type sucrose isomerase, the mutant had significantly improved thermal stability and fermentation activity. The immobilized enzyme prepared by the mutant has higher activity, significantly increased stability, improved sucrose conversion rate and isomaltulose generation rate, and lower impurity content, which is more suitable for industrial application.

Description

Sucrose isomerase mutant and application thereof
Technical Field
The invention belongs to the technical field of enzyme engineering, and relates to a sucrose isomerase mutant and application thereof.
Background
Sucrose isomerase (EC 5.4.99.11) is an enzyme capable of converting sucrose into isomaltulose or trehalulose. Compared with sucrose, isomaltulose (Palatinose) not only has the physical and chemical properties and mouthfeel similar to those of sucrose, but also has the advantages of good acid stability, low hygroscopicity, high safety and the like, and has wide market application prospect in food. Meanwhile, isomaltulose is used as a novel sweetener, has the advantages of low sweetness (about half of that of cane sugar), no decayed tooth, low calorie and the like, and is particularly suitable for patients with diabetes and obesity. In addition, the functional sugar alcohol can be used as a precursor for producing novel functional edible sugar alcohol.
At present, the research on the production method of isomaltulose mainly comprises four methods, namely an enzyme catalysis method, a microbial transformation method, a synthetic chemistry method and a plant transformation method. The isomaltulose produced by the chemical synthesis method is difficult and easily pollutes the environment. Although the medium Pueraria achieves the conversion of sucrose in plants to obtain isomaltulose, the method also has the problems of immature technology, low repetition rate, high environmental requirement, long period, high cost and the like. Thus, the biological method remains a method for mainly producing isomaltulose. In 1984, Nippon Xin Mitsui company successfully developed a special enzyme technology to industrially produce isomaltulose in large quantities. The prior process for preparing isomaltulose still mainly adopts microbial fermentation production, but the problems that sucrose and other heterosugars are difficult to separate, the obtained isomaltulose has low purity, the preparation process is complex, the production cost is high, a large amount of labor resources are consumed and the like exist in the preparation process.
With the rapid development of genetic engineering technology, sucrose isomerases from different sources are heterologously expressed in escherichia coli, and the yield of the enzymes is remarkably improved. The growing maturity of heterologous expression technologies solves the problem of low enzyme yields. Currently, the conversion rate for the production of isomaltulose by enzymatic conversion is between 65 and 92%. Wherein, the Liu Tong and the like successfully express sucrose isomerase derived from pantoea dispersa in Escherichia coli BL21, and the conversion rate of free enzyme after optimizing the enzyme conversion condition is the highest level reported by domestic and foreign documents and reaches 92.0%. The isomaltulose has high purity, and downstream can obtain the high-purity isomaltulose by only a simple purification and crystallization process, thereby obviously reducing the generation difficulty and the cost.
However, neither wild-type sucrose isomerase nor the reported modified enzyme can achieve both good stability and high conversion rate. Poor stability will lead to difficulty in continuous industrial enzyme conversion of sucrose isomerase and storage and transportation of the enzyme, low conversion rate not only increases difficulty for development of downstream process, but also leads to waste of raw materials, both of which result in high cost of enzyme preparation of isomaltulose, and thus, the enzyme preparation cannot be applied in large scale. Therefore, the development of a sucrose isomerase mutant with both stability and conversion rate is urgently needed to be applied to the industrial production of isomaltulose in a large scale. Based on the purpose, the invention carries out mutation screening on the pantoea dispersata-source sucrose isomerase with high conversion rate, and further improves the activity and stability of the enzyme without reducing the conversion rate, so that the pantoea dispersata-source sucrose isomerase is more suitable for industrial application.
Disclosure of Invention
The invention aims to provide a sucrose isomerase mutant so as to enable the mutant to have higher activity and stability than wild sucrose isomerase, and increase continuous reaction batches of sucrose isomerase immobilized enzymes to meet industrial use requirements.
To achieve this object, in a basic embodiment, the present invention provides a sucrose isomerase mutant having a mutation in the amino acid sequence shown in SEQ ID NO.1 at an amino acid position including at least one of R434P and E273N.
Furthermore, the amino acid sequences of the two-point mutant of R434P and E273N are shown as SEQ ID NO. 2.
The second objective of the invention is to provide a polynucleotide encoding the sucrose isomerase mutant, so that the encoded sucrose isomerase mutant has higher activity and stability than the wild sucrose isomerase, and the continuous reaction batches of the sucrose isomerase immobilized enzyme are increased, thereby meeting the industrial use requirements.
To achieve this object, in a basic embodiment, the present invention provides a polynucleotide encoding the aforementioned sucrose isomerase mutant.
The third purpose of the invention is to provide the application of the sucrose isomerase mutant: used for catalyzing sucrose reaction to better prepare isomaltulose.
To achieve the object, in a basic embodiment, the present invention provides a use of a sucrose isomerase mutant for catalyzing a sucrose reaction with the sucrose isomerase mutant as described above in a reaction system to produce isomaltulose.
Further, in the reaction system, the enzyme activity of the sucrose isomerase mutant is 60-150U/g substrate sucrose.
Furthermore, in the reaction system, the concentration of sucrose is 30-70%.
Further, the reaction temperature is 25-40 ℃, and the reaction time is 120-180 min.
Further, the reaction pH was 5.5 to 7.0.
Further, the reaction stirring speed is 150-.
Further, the sucrose isomerase mutant is an immobilized sucrose isomerase mutant.
The sucrose isomerase mutant has the beneficial effects that the sucrose isomerase mutant has higher stability and fermentation activity than wild sucrose isomerase. Meanwhile, the sucrose conversion rate and the isomaltulose generation rate are improved, the impurity content is lower, and the prepared immobilized enzyme can continuously react in multiple batches, thereby meeting the requirements of industrial application.
The sucrose isomerase SIM from the disperse Pantoea is selected as a starting point, and compared with the SIMs from other sources, the sucrose isomerase SIM has the following advantages: the product inhibition is small, the catalytic efficiency is high, and the final product concentration is high. On the basis, the SIM is mutated by means of genetic engineering and enzyme engineering technology, and the obtained SIM-1 mutant has the advantages of improving enzyme fermentation activity by 3 times, improving thermal stability by 4 times, obviously improving immobilized enzyme activity and stability and the like compared with the SIM, and is more suitable for synthesis of isomaltulose because the sucrose conversion rate and the isomaltulose generation rate are improved and the impurity content is lower.
Drawings
FIG. 1 is a schematic diagram of isomaltulose synthesis.
Detailed Description
The present invention is further illustrated by, but is not limited to, the following examples.
The enzyme activity of the SIM and the mutant thereof is determined as follows.
Sucrose with a mass concentration of 15% was prepared as a substrate solution using 0.05mol/L of a citric acid-disodium hydrogen phosphate buffer solution with pH 6.5.
And (3) measuring the enzyme activity of the crude enzyme solution: adding 1ml of crude enzyme solution into 10ml of substrate solution at 30 ℃ and pH6.5, reacting for 10min, and calculating the enzyme activity according to the amount of isomaltulose produced.
Enzyme activity determination of fermentation thalli: taking 50mL of zymocyte liquid, centrifuging at 12000r/min, removing supernatant, collecting thalli, re-suspending the thalli by using 50mL of normal saline, ultrasonically crushing (the ultrasonic time is 3s each time, the interval time is 2s, the ultrasonic frequency is 99 times, the ultrasonic power is 500W), taking 1mL of crushed liquid after completion, adding 10mL of reaction substrate, controlling the temperature at 30 ℃, stirring at the rotating speed of 150r/min, reacting for 10min, sampling 1mL after completion, and performing enzyme activity determination by using HPLC.
Enzyme activity determination of immobilized enzyme: accurately weighing 0.1g of immobilized enzyme, adding the immobilized enzyme into 10mL of reaction substrate for reaction, controlling the temperature at 30 ℃, stirring at the rotating speed of 150r/min, reacting for 10min, sampling 1mL of immobilized enzyme after the reaction is finished, and performing enzyme activity determination by using HPLC.
The HPLC measurement conditions were as follows:
liquid phase conditions: mobile phase: 75% acetonitrile in water
A chromatographic column: amide-805 um, 4.6 x 250mm
A detector: RID
Column temperature: 75 deg.C
Flow rate: 1.0ml/min
Sample introduction amount: 10 μ l
Peak time of each substance: sucrose: 13.844min
Isomaltulose: 14.929min
Glucose: 3.317min
Unit of enzyme activity: the amount of enzyme required to produce 1. mu. mol of isomaltulose per minute at a temperature of 30 ℃ and a pH of 6.5 is one unit (1U).
Example 1: construction of Pantoea dispersa-derived sucrose isomerase zymogen nuclear expression strain
Downloading an amino acid sequence (SEQ ID NO.1, corresponding to GenBank accession number: AAP57083.1) of Sucrose Isomerase (SIM) from Pantoea dispersa in GenBank, removing 1-21 signal peptide (MFLNGFKTVIALTMASSFYLA), and providing the signal peptide for Beijing Ongchoideae biotechnology Limited company to perform whole gene synthesis of coding nucleic acid (adopting preferred codon of Escherichia coli). The C-end of the synthetic gene is provided with a His label (the pET30a (+) vector is provided with the His label), the synthetic gene is constructed into a prokaryotic expression vector pET30a (+), and the restriction enzyme site of the prokaryotic expression vector is as follows: nde I at the 5 'end, Xho I at the 3' end. Passing the constructed plasmid pET30a (+) -SIM through CaCl2The heat shock transformation method is used for transforming the strain into an escherichia coli expression strain BL21(DE3), the strain is coated on an LB solid medium plate containing 50 mu g/ml Kanamycin, the plate is cultured overnight at 37 ℃, and a colony growing on the plate is the sucrose isomerase zymogen nuclear expression recombinant strain E.coli BL21(DE3)/pET30a (+) -SIM.
Carefully picking out a single colony of the sucrose isomerase zymogen nuclear expression recombinant strain in the LB solid culture medium plate by using a sterilized gun head, inoculating the single colony into a triangular flask containing 20mL of LB liquid culture medium, culturing at 37 ℃ at 200r/min, and shaking overnight. Inoculating the shake flask bacterial liquid into a triangular flask containing 100mL of TB liquid culture medium according to the inoculation amount of 1% the next day, carrying out shake culture at 37 ℃ at 220r/min, measuring the OD value of the culture solution every 1h, supplementing lactose with the final concentration of 1% (m/v) when the OD value of the culture solution is 1.5, continuously culturing at 25 ℃ at 220rpm for 4-6 h, and stopping culturing.
Example 2: purification and immobilization of Pantoea dispersa-derived sucrose isomerase
The fermentation broth obtained in example 1 was purified for protein using activated IDA Resin (His. bind Resin, Ni-charged, available from Annuan Biotech Ltd., Beijing) using His tag carried in the SIM recombinant protein, in the following manner: centrifuging the fermentation liquid for 10min at 4 ℃ and 10000r/min, discarding the supernatant, collecting the thallus, repeatedly washing the thallus twice with phosphate buffer solution (pH 7.5 and 0.1mol/L), centrifuging, and then concentrating the thallus by 5 times and suspending in 20ml of phosphate buffer solution (pH 7.5 and 0.1 mol/L). And (3) placing the treated bacterial liquid in ice water for ultrasonic crushing until the bacterial liquid is clarified, wherein the ultrasonic crushing conditions are as follows: work 2s, interval 5s, ultrasonic power 500W. And (3) placing the crushed lysate into a low-temperature high-speed centrifuge for centrifugation (12000rpm, 4 ℃ and 20min), and collecting supernatant to obtain crude protein. Loading the crude protein onto the activated IDA resin, performing gradient elution by using imidazole solution (10mM-300mM), performing real-time monitoring by using a protein chromatography system (Bio-Rad), and collecting the stable protein peak, namely the SIM recombinant protein purified protein, for preparing the immobilized enzyme.
The purified SIM recombinant protein is used for preparing immobilized enzyme, and the specific method comprises the following steps:
(1) activating an immobilized carrier: 30ml of 60% (m/v) glutaraldehyde and dipotassium hydrogen phosphate (K) are accurately measured2HPO4·3H2O)4.76g is added into 600ml deionized water, after dissolution, the volume is adjusted to 1000ml by deionized water, and the pH value is adjusted to 8.0 by phosphoric acid solution. An epoxy-based carrier ECEP (Resindions S.r.l. Italy) of 250g was put into the above solution and activated at 25 ℃ with low stirring for 2 hours, and the carrier was collected by filtration, washed 2 to 3 times with sterile deionized water and vacuum-filtered to dryness for use.
(2) Immobilization of SIM recombinant protein: diluting a certain amount of the purified SIM recombinant protein with a phosphate buffer solution (pH 6.5 and 0.5mol/L), adding 50g of the activated carrier, immobilizing for 16h at 25 ℃ and 120rpm, washing the obtained immobilized enzyme with the phosphate buffer solution (pH 6.5 and 0.02mol/L) for 3-5 times, and vacuum filtering to obtain the final immobilized enzyme product.
Example 3: construction of error-prone mutation library of SIM prokaryotic expression strain E.coli BL21(DE3)/pET30a (+) -SIM
pET30a (+) -SIM recombinant plasmid is used as PCR template, conventional T7F/R is used as universal primer (primer sequence: T7F: 5'-TAATACGACTCACTATAGGG-3' T7R: GCTAGTTATTGCTCAGCGG is shown in SEQ ID NO.3 and 4) to carry out error-prone PCR amplification on SIM gene, and Mg in a PCR amplification reaction system is adjusted2+、Mn2+dCTP and dTTP oligonucleotide concentration, base-mismatching of the mutant libraryThe rate is only two thousandth, that is, only 1 to 2 amino acids of one mutant are mutated.
Error-prone PCR reaction system:
Figure BDA0003188099660000051
error-prone PCR reaction conditions: pre-denaturation at 95 ℃ for 5 min; then denaturation at 94 ℃ for 30s, annealing at 56 ℃ for 1min, and extension at 72 ℃ for 1.5min for 25 cycles; finally, extension is carried out for 10min at 72 ℃.
And sampling 2 mu L of the error-prone PCR product, detecting the error-prone PCR product through agarose gel electrophoresis, and purifying the error-prone PCR product by using a PCR product purification kit after the error-prone PCR product is detected. The PCR purified product and the prokaryotic expression vector pET30a (+) were subjected to double digestion with Nde I and Xho I restriction enzymes at 37 ℃ respectively, and the digestion product was subjected to gel cutting and recovery (wherein the size of the recovered PCR purified product fragment is about 1700bp, and the size of the recovered vector pET30a (+) fragment is about 5400bp) followed by error-prone PCR: the prokaryotic expression vector pET30a (+) is 3: 1, and T4DNA ligase was added thereto and ligated overnight at 16 ℃. The next day, the ligation product is transferred into escherichia coli BL21(DE3) by an electric shock transformation method to construct engineering bacteria, and a random mutant library with large library capacity can be obtained.
Example 4: screening of error-prone mutation library of SIM prokaryotic expression strain E.coli BL21(DE3)/pET30a (+) -SIM
The screening principle is as follows:
based on the principle that a fibhlin reagent can react with reducing sugar to generate brick red precipitate, sucrose as a substrate is non-reducing sugar, and the product isomaltulose (reducing sugar) can be identified by using the fibhlin reagent.
The specific method comprises the following steps:
using the sterilized toothpicks, single colonies of the mutant library (1 single colony per toothpick) were carefully picked and inoculated into different wells of a 96-well cell culture plate (LB liquid medium containing 50. mu.g/ml kanamycin had been added to each well). The 96-well cell culture plates were incubated for 6 hours at 37 ℃ and 700rpm in a constant temperature shaker, then lactose was added to each well using an 8-channel pipette to a final concentration of 1% (m/v), and incubation was induced for 8 hours at 25 ℃ and 250 rpm. After induction culture is finished, a 96-hole cell culture plate is placed into an ultralow temperature refrigerator with the temperature of minus 86 ℃ for freezing for 2 hours, the cell culture plate is taken out and placed at the room temperature for half an hour and then 4000r/min, the cell culture plate is centrifuged at the temperature of 4 ℃ for 20 minutes, and 100 mu L of supernatant is taken out of each hole and is placed at the temperature of 47 ℃ for standing for 30 minutes. After warming up, 25. mu.L of the supernatant from each well was transferred to a new 96-well plate, and 50. mu.L of 50% sucrose (prepared with 0.05mol/L phosphate buffer, pH 6.5) was added thereto and reacted at 30 ℃ for 120 min. Then 50 μ l of film formazan was added: the mixed solution of ethyl-5: 1 was developed at 60 ℃ for 30 min. The color change was observed.
Through repeated mass screening verification (about 140000 clones), sequencing analysis and enzyme activity determination, an SIM mutant strain with 4-fold improved thermal stability and 3-fold improved zymolase activity, namely an SIM-1 expression strain, is obtained, and is subjected to two-point mutation of R434P and E273N.
Example 5: comparison of immobilized enzyme-catalyzed isomaltulose Synthesis reactions of the mutant strains and the control strains
The immobilized enzymes were prepared from SIM-1 and SIM respectively (same method as in example 2) to catalyze the isomaltulose synthesis reaction.
Reaction conditions are as follows: accurately weighing 50.0g of sucrose, dissolving with deionized water, fixing the volume to 100ml (the concentration is 50%), adding 0.2g of sucrose isomerase immobilized enzyme into each gram of sucrose, reacting at 30 ℃ and pH6.5 at 180r/min, sampling, detecting a liquid phase, performing suction filtration to obtain a reaction solution after the reaction is finished, top washing the immobilized enzyme with 100ml of 2mmol/L phosphate buffer solution with pH6.5, mixing the top washing solution into the reaction solution for the same volume, detecting the concentration, calculating the yield, and adding the top-washed enzyme into the next batch for reaction. The batch reaction of SIM-1 and SIM is shown in tables 1 and 2 below.
TABLE 1SIM-1 batch reaction
Figure BDA0003188099660000061
Figure BDA0003188099660000071
Figure BDA0003188099660000081
TABLE 2SIM batch reactions
Figure BDA0003188099660000082
The table results show that the activity of the mutant SIM-1 immobilized enzyme is improved by about 54 percent compared with the wild type SIM immobilized enzyme, the activity of the immobilized enzyme is integrally kept stable after 33 batches of reactions, the reaction time is stabilized at 2-2.5h, the activity of the SIM immobilized enzyme is obviously reduced after each batch of reactions, and the reaction time is also obviously prolonged. Obviously, compared with wild immobilized enzyme, the activity and stability of the mutant are obviously improved. In addition, the mutant SIM-1 immobilized enzyme can completely convert the sucrose, and the isomaltulose production rate reaches 96.98% at most. And the wild type SIM immobilized enzyme is converted with a small amount of sucrose residues, and the highest isomaltulose production rate is 90.26%, which shows that the mutant is improved in substrate conversion rate and product production rate compared with the wild type immobilized enzyme.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is intended to include such modifications and variations. The foregoing examples or embodiments are merely illustrative of the present invention, which may be embodied in other specific forms or in other specific forms without departing from the spirit or essential characteristics thereof. The described embodiments are, therefore, to be considered in all respects as illustrative and not restrictive. The scope of the invention should be indicated by the appended claims, and any changes that are equivalent to the intent and scope of the claims should be construed to be included therein.
Sequence listing
<110> Hunan Fulaige Biotechnology Ltd
<120> sucrose isomerase mutant and application thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 579
<212> PRT
<213> Pantoea dispersa
<400> 1
Ala Ser Pro Leu Thr Lys Pro Ser Thr Pro Ile Ala Ala Thr Asn Ile
1 5 10 15
Gln Lys Ser Ala Asp Phe Pro Ile Trp Trp Lys Gln Ala Val Phe Tyr
20 25 30
Gln Ile Tyr Pro Arg Ser Phe Lys Asp Ser Asn Gly Asp Gly Ile Gly
35 40 45
Asp Ile Pro Gly Ile Ile Glu Lys Leu Asp Tyr Leu Lys Met Leu Gly
50 55 60
Val Asp Ala Ile Trp Ile Asn Pro His Tyr Glu Ser Pro Asn Thr Asp
65 70 75 80
Asn Gly Tyr Asp Ile Ser Asp Tyr Arg Lys Ile Met Lys Glu Tyr Gly
85 90 95
Ser Met Ala Asp Phe Asp Arg Leu Val Ala Glu Met Asn Lys Arg Gly
100 105 110
Met Arg Leu Met Ile Asp Ile Val Ile Asn His Thr Ser Asp Arg His
115 120 125
Arg Trp Phe Val Gln Ser Arg Ser Gly Lys Asp Asn Pro Tyr Arg Asp
130 135 140
Tyr Tyr Phe Trp Arg Asp Gly Lys Gln Gly Gln Ala Pro Asn Asn Tyr
145 150 155 160
Pro Ser Phe Phe Gly Gly Ser Ala Trp Gln Leu Asp Lys Gln Thr Asp
165 170 175
Gln Tyr Tyr Leu His Tyr Phe Ala Pro Gln Gln Pro Asp Leu Asn Trp
180 185 190
Asp Asn Pro Lys Val Arg Ala Glu Leu Tyr Asp Ile Leu Arg Phe Trp
195 200 205
Leu Asp Lys Gly Val Ser Gly Leu Arg Phe Asp Thr Val Ala Thr Phe
210 215 220
Ser Lys Ile Pro Gly Phe Pro Asp Leu Ser Lys Ala Gln Leu Lys Asn
225 230 235 240
Phe Ala Glu Ala Tyr Thr Glu Gly Pro Asn Ile His Lys Tyr Ile His
245 250 255
Glu Met Asn Arg Gln Val Leu Ser Lys Tyr Asn Val Ala Thr Ala Gly
260 265 270
Glu Ile Phe Gly Val Pro Val Ser Ala Met Pro Asp Tyr Phe Asp Arg
275 280 285
Arg Arg Glu Glu Leu Asn Ile Ala Phe Thr Phe Asp Leu Ile Arg Leu
290 295 300
Asp Arg Tyr Pro Asp Gln Arg Trp Arg Arg Lys Pro Trp Thr Leu Ser
305 310 315 320
Gln Phe Arg Gln Val Ile Ser Gln Thr Asp Arg Ala Ala Gly Glu Phe
325 330 335
Gly Trp Asn Ala Phe Phe Leu Asp Asn His Asp Asn Pro Arg Gln Val
340 345 350
Ser His Phe Gly Asp Asp Ser Pro Gln Trp Arg Glu Arg Ser Ala Lys
355 360 365
Ala Leu Ala Thr Leu Leu Leu Thr Gln Arg Ala Thr Pro Phe Ile Phe
370 375 380
Gln Gly Ala Glu Leu Gly Met Thr Asn Tyr Pro Phe Lys Asn Ile Glu
385 390 395 400
Glu Phe Asp Asp Ile Glu Val Lys Gly Phe Trp Asn Asp Tyr Val Ala
405 410 415
Ser Gly Lys Val Asn Ala Ala Glu Phe Leu Gln Glu Val Arg Met Thr
420 425 430
Ser Arg Asp Asn Ser Arg Thr Pro Met Gln Trp Asn Asp Ser Val Asn
435 440 445
Ala Gly Phe Thr Gln Gly Lys Pro Trp Phe His Leu Asn Pro Asn Tyr
450 455 460
Lys Gln Ile Asn Ala Ala Arg Glu Val Asn Lys Pro Asp Ser Val Phe
465 470 475 480
Ser Tyr Tyr Arg Gln Leu Ile Asn Leu Arg His Gln Ile Pro Ala Leu
485 490 495
Thr Ser Gly Glu Tyr Arg Asp Leu Asp Pro Gln Asn Asn Gln Val Tyr
500 505 510
Ala Tyr Thr Arg Ile Leu Asp Asn Glu Lys Tyr Leu Val Val Val Asn
515 520 525
Phe Lys Pro Glu Gln Leu His Tyr Ala Leu Pro Asp Asn Leu Thr Ile
530 535 540
Ala Ser Ser Leu Leu Glu Asn Val His Gln Pro Ser Leu Gln Glu Asn
545 550 555 560
Ala Ser Thr Leu Thr Leu Ala Pro Trp Gln Ala Gly Ile Tyr Lys Leu
565 570 575
Asn Leu Glu
<210> 2
<211> 579
<212> PRT
<213> Pantoea dispersa (Pantoea dispersa)
<400> 2
Ala Ser Pro Leu Thr Lys Pro Ser Thr Pro Ile Ala Ala Thr Asn Ile
1 5 10 15
Gln Lys Ser Ala Asp Phe Pro Ile Trp Trp Lys Gln Ala Val Phe Tyr
20 25 30
Gln Ile Tyr Pro Arg Ser Phe Lys Asp Ser Asn Gly Asp Gly Ile Gly
35 40 45
Asp Ile Pro Gly Ile Ile Glu Lys Leu Asp Tyr Leu Lys Met Leu Gly
50 55 60
Val Asp Ala Ile Trp Ile Asn Pro His Tyr Glu Ser Pro Asn Thr Asp
65 70 75 80
Asn Gly Tyr Asp Ile Ser Asp Tyr Arg Lys Ile Met Lys Glu Tyr Gly
85 90 95
Ser Met Ala Asp Phe Asp Arg Leu Val Ala Glu Met Asn Lys Arg Gly
100 105 110
Met Arg Leu Met Ile Asp Ile Val Ile Asn His Thr Ser Asp Arg His
115 120 125
Arg Trp Phe Val Gln Ser Arg Ser Gly Lys Asp Asn Pro Tyr Arg Asp
130 135 140
Tyr Tyr Phe Trp Arg Asp Gly Lys Gln Gly Gln Ala Pro Asn Asn Tyr
145 150 155 160
Pro Ser Phe Phe Gly Gly Ser Ala Trp Gln Leu Asp Lys Gln Thr Asp
165 170 175
Gln Tyr Tyr Leu His Tyr Phe Ala Pro Gln Gln Pro Asp Leu Asn Trp
180 185 190
Asp Asn Pro Lys Val Arg Ala Glu Leu Tyr Asp Ile Leu Arg Phe Trp
195 200 205
Leu Asp Lys Gly Val Ser Gly Leu Arg Phe Asp Thr Val Ala Thr Phe
210 215 220
Ser Lys Ile Pro Gly Phe Pro Asp Leu Ser Lys Ala Gln Leu Lys Asn
225 230 235 240
Phe Ala Glu Ala Tyr Thr Glu Gly Pro Asn Ile His Lys Tyr Ile His
245 250 255
Glu Met Asn Arg Gln Val Leu Ser Lys Tyr Asn Val Ala Thr Ala Gly
260 265 270
Asn Ile Phe Gly Val Pro Val Ser Ala Met Pro Asp Tyr Phe Asp Arg
275 280 285
Arg Arg Glu Glu Leu Asn Ile Ala Phe Thr Phe Asp Leu Ile Arg Leu
290 295 300
Asp Arg Tyr Pro Asp Gln Arg Trp Arg Arg Lys Pro Trp Thr Leu Ser
305 310 315 320
Gln Phe Arg Gln Val Ile Ser Gln Thr Asp Arg Ala Ala Gly Glu Phe
325 330 335
Gly Trp Asn Ala Phe Phe Leu Asp Asn His Asp Asn Pro Arg Gln Val
340 345 350
Ser His Phe Gly Asp Asp Ser Pro Gln Trp Arg Glu Arg Ser Ala Lys
355 360 365
Ala Leu Ala Thr Leu Leu Leu Thr Gln Arg Ala Thr Pro Phe Ile Phe
370 375 380
Gln Gly Ala Glu Leu Gly Met Thr Asn Tyr Pro Phe Lys Asn Ile Glu
385 390 395 400
Glu Phe Asp Asp Ile Glu Val Lys Gly Phe Trp Asn Asp Tyr Val Ala
405 410 415
Ser Gly Lys Val Asn Ala Ala Glu Phe Leu Gln Glu Val Arg Met Thr
420 425 430
Ser Pro Asp Asn Ser Arg Thr Pro Met Gln Trp Asn Asp Ser Val Asn
435 440 445
Ala Gly Phe Thr Gln Gly Lys Pro Trp Phe His Leu Asn Pro Asn Tyr
450 455 460
Lys Gln Ile Asn Ala Ala Arg Glu Val Asn Lys Pro Asp Ser Val Phe
465 470 475 480
Ser Tyr Tyr Arg Gln Leu Ile Asn Leu Arg His Gln Ile Pro Ala Leu
485 490 495
Thr Ser Gly Glu Tyr Arg Asp Leu Asp Pro Gln Asn Asn Gln Val Tyr
500 505 510
Ala Tyr Thr Arg Ile Leu Asp Asn Glu Lys Tyr Leu Val Val Val Asn
515 520 525
Phe Lys Pro Glu Gln Leu His Tyr Ala Leu Pro Asp Asn Leu Thr Ile
530 535 540
Ala Ser Ser Leu Leu Glu Asn Val His Gln Pro Ser Leu Gln Glu Asn
545 550 555 560
Ala Ser Thr Leu Thr Leu Ala Pro Trp Gln Ala Gly Ile Tyr Lys Leu
565 570 575
Asn Leu Glu
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
taatacgact cactataggg 20
<210> 4
<211> 19
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
gctagttatt gctcagcgg 19

Claims (10)

1. A sucrose isomerase mutant, characterized in that: the amino acid sequence shown in SEQ ID NO.1 is mutated, and the mutated amino acid site comprises at least one of R434P and E273N.
2. The mutant according to claim 1, characterized in that: the amino acid sequences of the two-point mutants of R434P and E273N are shown in SEQ ID NO. 2.
3. A nucleotide encoding the sucrose isomerase mutant of claim 1 or 2.
4. Use of a sucrose isomerase mutant as claimed in claim 1 or 2 wherein: used for catalyzing sucrose reaction to prepare isomaltulose.
5. Use according to claim 4, characterized in that: in the reaction system, the enzyme activity of the sucrose isomerase mutant is 60-150U/g substrate sucrose.
6. Use according to claim 4, characterized in that: in the reaction system, the concentration of the sucrose is 30-70%.
7. Use according to claim 4, characterized in that: the reaction temperature is 25-40 ℃, and the reaction time is 120-180 min.
8. Use according to claim 4, characterized in that: the reaction pH is 5.5-7.0.
9. Use according to claim 4, characterized in that: the reaction stirring speed is 150-200 r/min.
10. Use according to claim 4, characterized in that: the sucrose isomerase mutant is an immobilized sucrose isomerase mutant.
CN202110868362.2A 2021-07-30 2021-07-30 A sucrose isomerase mutant and its application Active CN113481189B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110868362.2A CN113481189B (en) 2021-07-30 2021-07-30 A sucrose isomerase mutant and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110868362.2A CN113481189B (en) 2021-07-30 2021-07-30 A sucrose isomerase mutant and its application

Publications (2)

Publication Number Publication Date
CN113481189A true CN113481189A (en) 2021-10-08
CN113481189B CN113481189B (en) 2022-06-24

Family

ID=77943578

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110868362.2A Active CN113481189B (en) 2021-07-30 2021-07-30 A sucrose isomerase mutant and its application

Country Status (1)

Country Link
CN (1) CN113481189B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114085824A (en) * 2021-12-08 2022-02-25 广西科学院 Sucrose isomerase mutant, construction method and application thereof, recombinant expression vector and recombinant bacterium
CN114134136A (en) * 2021-11-30 2022-03-04 南京诺云生物科技有限公司 Rapid isomaltulose preparation method under high reaction concentration and sucrose isomerase prepared by rapid isomaltulose preparation method

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2681324A1 (en) * 2011-03-03 2014-01-08 Targeted Growth, Inc. Expression of isomers of sucrose increases seed weight, seed number and/or seed size
CN104059901A (en) * 2014-05-06 2014-09-24 江南大学 Sucrose isomerase mutants with improved heat stability and secretion efficiency and preparation method thereof
CN104762286A (en) * 2015-03-30 2015-07-08 江南大学 Sucrose isomerase mutant with improved thermal stability and catalytic efficiency
KR20160014818A (en) * 2014-07-29 2016-02-12 경희대학교 산학협력단 Mutated sucrose isomerase and process for preparing the same
CN105483107A (en) * 2015-12-31 2016-04-13 天津科技大学 A kind of sucrose isomerase mutant and its method for producing isomaltulose
CN106367377A (en) * 2016-09-22 2017-02-01 江南大学 Immobilization method of sucrose isomerase
CN107189998A (en) * 2017-04-19 2017-09-22 威尔金有限责任公司 A kind of sucrose isomerase enzyme mutant and its application
CN111087476A (en) * 2019-12-31 2020-05-01 天津科技大学 A kind of double signal peptide for improving the expression of exogenous protein and its construction method and use
WO2020099425A1 (en) * 2018-11-14 2020-05-22 Evonik Operations Gmbh Isomaltulose production
CN113151237A (en) * 2021-05-21 2021-07-23 江南大学 Sucrose isomerase mutant with improved stability and construction method thereof
CN113174385A (en) * 2021-04-13 2021-07-27 苏州朗邦营养科技有限公司 Sucrose isomerase mutant with high activity and high conversion rate and application thereof

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2681324A1 (en) * 2011-03-03 2014-01-08 Targeted Growth, Inc. Expression of isomers of sucrose increases seed weight, seed number and/or seed size
US20140068817A1 (en) * 2011-03-03 2014-03-06 Targeted Growth, Inc. Expression of isomers of sucrose increases seed weight, seed number and/or seed size
CN104059901A (en) * 2014-05-06 2014-09-24 江南大学 Sucrose isomerase mutants with improved heat stability and secretion efficiency and preparation method thereof
KR20160014818A (en) * 2014-07-29 2016-02-12 경희대학교 산학협력단 Mutated sucrose isomerase and process for preparing the same
CN104762286A (en) * 2015-03-30 2015-07-08 江南大学 Sucrose isomerase mutant with improved thermal stability and catalytic efficiency
CN105483107A (en) * 2015-12-31 2016-04-13 天津科技大学 A kind of sucrose isomerase mutant and its method for producing isomaltulose
CN106367377A (en) * 2016-09-22 2017-02-01 江南大学 Immobilization method of sucrose isomerase
CN107189998A (en) * 2017-04-19 2017-09-22 威尔金有限责任公司 A kind of sucrose isomerase enzyme mutant and its application
WO2020099425A1 (en) * 2018-11-14 2020-05-22 Evonik Operations Gmbh Isomaltulose production
CN111087476A (en) * 2019-12-31 2020-05-01 天津科技大学 A kind of double signal peptide for improving the expression of exogenous protein and its construction method and use
CN113174385A (en) * 2021-04-13 2021-07-27 苏州朗邦营养科技有限公司 Sucrose isomerase mutant with high activity and high conversion rate and application thereof
CN113151237A (en) * 2021-05-21 2021-07-23 江南大学 Sucrose isomerase mutant with improved stability and construction method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HYEON CHEOL LEE等: "Isomaltose Production by Modification of the Fructose-Binding Site on the Basis of the Predicted Structure of Sucrose Isomerase from "Protaminobacter rubrum"", 《APPL.ENVIRON.MICROBIOL.》, vol. 74, no. 16, 31 August 2008 (2008-08-31), pages 5183 - 5194 *
WU LUGUANG等: "Characterization of the Highly Efficient Sucrose Isomerase from Pantoea dispersa UQ68J and Cloning of the Sucrose Isomerase Gene", 《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》, vol. 71, no. 3, 31 March 2005 (2005-03-31), pages 1581 - 1590 *
唐文竹等: "蔗糖异构酶催化生产异麦芽酮糖研究进展", 《微生物学通报》, vol. 39, no. 9, 20 September 2012 (2012-09-20), pages 1314 - 1322 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114134136A (en) * 2021-11-30 2022-03-04 南京诺云生物科技有限公司 Rapid isomaltulose preparation method under high reaction concentration and sucrose isomerase prepared by rapid isomaltulose preparation method
CN114134136B (en) * 2021-11-30 2023-09-08 南京诺云生物科技有限公司 A rapid preparation method of isomaltulose and its sucrose isomerase at high reaction concentration
CN114085824A (en) * 2021-12-08 2022-02-25 广西科学院 Sucrose isomerase mutant, construction method and application thereof, recombinant expression vector and recombinant bacterium
CN114085824B (en) * 2021-12-08 2023-02-24 广西科学院 A sucrose isomerase mutant, its construction method and application, a recombinant expression vector and recombinant bacteria

Also Published As

Publication number Publication date
CN113481189B (en) 2022-06-24

Similar Documents

Publication Publication Date Title
CN109609530B (en) Trehalose synthetase and application thereof in trehalose production
CN112251428B (en) Glutamic acid decarboxylase mutant and application thereof in production of gamma-aminobutyric acid
CN111206009B (en) Genetic engineering bacterium for high yield of D-psicose and application thereof
CN110862980B (en) A D-psicose 3-epimerase mutant and its application
CN113481189A (en) A sucrose isomerase mutant and its application
CN110904088A (en) High-temperature-resistant D-psicose3-epimerase, mutant and application thereof
CN113174385B (en) Sucrose isomerase mutant with high activity and high conversion rate and application thereof
CN111235126B (en) A kind of S-adenosylmethionine synthase mutant and its preparation method
CN105087533B (en) A kind of mutant of penicillin G acylase and its preparation method and application
CN111394410B (en) High-catalytic-activity neuraminic acid synthase and application thereof
CN114107270A (en) A L-aspartate β-decarboxylase mutant
CN107400667B (en) A kind of immobilization method for cells containing recombinant high temperature resistant glucose isomerase
CN117660562A (en) A method for biosynthesizing D-tagatose using recombinant Bacillus subtilis and isolating and purifying its product
CN106119235B (en) A kind of DPE and its application from bulkholderia cepasea
CN110951717B (en) A kind of L-arabinose isomerase isomer and its application
CN109161540B (en) A kind of penicillin V acylase mutant, coding sequence, recombinant expression vector, genetic engineering bacteria and application
CN110904087B (en) L-arabinose epimerase mutants and their applications
CN113151240A (en) Glucose isomerase, mutant, coding gene and application thereof
CN111057698B (en) L-arabinose isomerase, mutants and their applications
CN118308329B (en) β-N-acetylhexosaminidase D297K and its application
CN111057697A (en) Heat-resistant TIM barrel protein mutants and their applications
CN119320766B (en) A tagatose-4-epimerase mutant and its application
CN117625585B (en) Bifunctional enzyme NagEA and application thereof
NL2038057B1 (en) Arabinose isomerase mutant and construction method and application thereof
CN113957065B (en) Sucrose isomerase with high conversion rate and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A sucrose isomerase mutant and its application

Granted publication date: 20220624

Pledgee: Changsha Bank city branch of Limited by Share Ltd.

Pledgor: HUNAN FLAG BIOTECHNOLOGY Co.,Ltd.

Registration number: Y2024980012003

PE01 Entry into force of the registration of the contract for pledge of patent right
PM01 Change of the registration of the contract for pledge of patent right

Change date: 20241220

Registration number: Y2024980012003

Pledgor after: Hunan Fulige Biotechnology Co., Ltd., Hunan Baoliesi Biotechnology Co.,Ltd.

Pledgor before: HUNAN FLAG BIOTECHNOLOGY Co.,Ltd.

PM01 Change of the registration of the contract for pledge of patent right